Tranexamic acid-induced visual impairment in a hemodialysis patient
暂无分享,去创建一个
T. Fujii | H. Kitamura | E. Imai | Y. Kuwayama | N. Itoh | I. Matsui | Yoshimasa Fujita | Y. Okazaki | M. Fujii | A. Okuno | Ryouhei Yamamoto | Masayo Aizawa
[1] T. Hosoya,et al. Three CAPD cases who maintained increased ultrafiltration volume by long-term and intermittent oral administration of low dose of tranexamic acid , 2001 .
[2] Y. Kawaguchi,et al. Tranexamic Acid Increases Peritoneal Ultrafiltration Volume in Patients on Capd , 1999, Peritoneal Dialysis International.
[3] J. Forrester,et al. An investigation of retinal function and structure in rabbits treated long-term with tranexamic acid. , 1977, Toxicology and applied pharmacology.
[4] A. Pilbrant,et al. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers , 1974, European Journal of Clinical Pharmacology.
[5] R. Chakrabarti,et al. Tranexamic acid in upper gastrointestinal haemorrhage. , 1973, Lancet.
[6] Y. Abiko,et al. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin. , 1970, Biochimica et biophysica acta.
[7] P. Hedlund,et al. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases , 2004, Urological Research.
[8] J. Vessman,et al. Pharmacokinetics and bioavailability of tranexamic acid , 2004, European Journal of Clinical Pharmacology.
[9] B. Åstedt. Clinical pharmacology of tranexamic acid. , 1987, Scandinavian journal of gastroenterology. Supplement.